Evidence map›Paper›PMID 42155647›Full record

ArticleJournal of substance use and addiction treatment2026

Organizational perspectives on barriers and facilitators to an integrated care model for opioid use disorder and serious injection-related infections.

Hilary L Surratt, Michelle R Lofwall, Elizabeth O Nelson, Alice C Thornton, Evelyn Villacorta Cari, Sharon L Walsh, Laura C Fanucchi

Abstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hilary L SurrattUKCOM, Department of Behavioral Science, Center on Drug and Alcohol Research, Lexington, KY, United States of America. Electronic address: hilary.surratt@uky.edu.
Michelle R LofwallUKCOM, Departments of Behavioral Science and Psychiatry, Center on Drug and Alcohol Research, Lexington, KY, United States of America.
Elizabeth O NelsonUKCOM, Department of Behavioral Science, Lexington, KY, United States of America.
Alice C ThorntonUKCOM, Department of Internal Medicine, Division of Infectious Diseases, Lexington, KY, United States of America.
Evelyn Villacorta CariUKCOM, Department of Internal Medicine, Division of Infectious Diseases, Lexington, KY, United States of America.
Sharon L WalshUKCOM, Departments of Behavioral Science and Psychiatry, Center on Drug and Alcohol Research, Lexington, KY, United States of America.
Laura C FanucchiUKCOM, Department of Internal Medicine, Division of Infectious Diseases, Center on Drug and Alcohol Research, Lexington, KY, United States of America.

Funding

DAT- Integrated Outpatient Treatment of Opioid Use Disorder and Injection-Related InfectionsR01DA048892 · NIDA · UNIVERSITY OF KENTUCKY · PI FANUCCHI, LAURA, LOFWALL, MICHELLE RENEE · 2020 to 2023
$2.8M
NIDA NIH HHS R01 DA048892
6 · The paper itself

Abstract

backgroundRising rates of serious injection-related infections (SIRI) and hospitalizations have been documented nationally in the context of the ongoing opioid and polysubstance use epidemic in the United States. This qualitative interview study assessed multi-level facilitators and barriers to the implementation of an integrated inpatient opioid use disorder (OUD) and SIRI care intervention among organizational stakeholders in the healthcare setting as a secondary aim of a randomized clinical trial.

methodsThe PRISM (Practical, Robust, Implementation, and Sustainability Model) implementation science framework guided stakeholder interviews. Eligible stakeholders were at least 18 years old and employed in an inpatient or outpatient care setting that served the study patient population. Qualitative interviews assessed contextual factors that supported or hindered the implementation of the novel study intervention and priorities for sustainability and future investment. Interviews lasted approximately 60 min. Qualitative coding and analysis were conducted in NVivo.

resultsOverall, thirteen stakeholders were interviewed, including clinicians from cardiothoracic surgery, hospital medicine, infectious disease, and addiction medicine, hospital administrators, social work and case management staff, pharmacists, Bridge Clinic staff, and staff from home infusion. Within the four overarching PRISM domains thirteen critical elements were activated by the study intervention that represented key barriers and facilitators to implementation, including: Intervention (Coordination across departments, Strength of the evidence base, Burden, Barriers of frontline staff, SUD stigma); Recipients (Clinical leadership, Organizational health and culture; Patient disease burden, Patient demographics); External Environment (Community Resources, Reimbursement); and Implementation and Sustainability Infrastructure (Dedicated team, Plan for sustainability).

conclusionsExamination of implementation determinants highlighted organizational and external barriers and facilitators. Barriers centered on the complexities of care coordination across departments, the inpatient-outpatient transition, and specialized training needs; these appeared modifiable through adoption of specific implementation strategies. The presence of critical clinical infrastructure to support this transitional OUD-SIRI integrated care model was an essential facilitator, which could represent a challenge for other health systems. External factors, including low resource availability, and SUD-related stigma that excludes patients from opportunities to receive care in the community, collectively pose challenges to wider implementation and sustainability.

Indexed as

Delivery of Health Care, IntegratedOpioid-Related DisordersSubstance Abuse, IntravenousAttitude of Health PersonnelHumansQualitative ResearchUnited StatesEvidence-based practiceHealthcare deliveryImplementation scienceOpioid use disorderQualitative researchSerious injection-related infections

Identifiers

PMID42155647
PMCPMC13249083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.